Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the Western world, with an estimated prevalence of approximately 25% [1, 2]. , 2022 ). 0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 2 [convert to ICD-9-CM] Code History. 81 for Nonalcoholic steatohepatitis (NASH) is a medical classification as listed by WHO under the range – Diseases of the digestive system . underlying liver disease, such as: nonalcoholic steatohepatitis (NASH) (. Chronic yellow atrophy (liver) Fatty liver, without mention. The 2024 edition of ICD-10-CM K74. This article will outline the causes, symptoms, diagnosis, treatment and the ICD 10 CM code for NASH. gastro. In 2013, NASH became the second leading. Fatty replacement and damage to the hepatocytes not related to alcohol use. 81) ICD-10-CM Diagnosis Code K74. Chart review was completed, and consensus definitions were used to assign certainty of diagnosis. 3. 0. doi: 10. Non-Alcoholic Fatty Liver Disease (NAFLD) is currently the most common cause of chronic liver disease worldwide, and its prevalence is increasing globally. Nonalcoholic Steatohepatitis (NASH): Treatment Test: 550960. 81 became effective on October 1, 2021. Nonalcoholic fatty liver disease, or NAFLD, refers to the buildup of excess fat in the liver. 8 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 571. 60 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The condition is characterised by excessive hepatic fat accumulation and is directly associated with. 38% in 2021) ( Younossi et al. K74. The 2024 edition of ICD-10-CM K70. Nonalcoholic steatohepatitis affects 3% to 6% of the US population, is more prevalent in patients with metabolic disease and obesity, progresses to cirrhosis in approximately 20% of cases, and is associated with increased rates of liver. 51 - other international versions of ICD-10 K71. Nonalcoholic fatty liver disease (NAFLD) is a spectrum of diseases ranging from simple hepatic steatosis to nonalcoholic steatohepatitis (NASH) to advanced fibrosis and cirrhosis as well as liver cancer. 24% in 2015 to 29. – ICD-10 diagnosis codes (K74. org There are two forms of NAFLD: nonalcoholic fatty liver (NAFL), defined as 5% or greater hepatic steatosis without hepatocellular injury or fibrosis, and nonalcoholic steatohepatitis (NASH. This assay currently is not available in New York state. 0. Non-alcoholic steatohepatitis. 5, K74. Long Description: Other chronic nonalcoholic liver disease. This is the first study using the ICD-10-CM code with a specific search code for NASH. Nonalcoholic fatty liver disease (NAFLD) affects one-fourth of the global population and is the most common cause of chronic liver disease. 8 ICD-9 Billable. 3 result found: ICD-10-CM Diagnosis Code K75. 7 Hepatorenal syndrome K76. Inflammation and liver cell damage can cause fibrosis, or scarring. It is found in the 2024 version of the ICD-10 Clinical Modification (CM) and can be used in all HIPAA-covered transactions from Oct 01, 2023 - Sep 30, 2024 . ICD-10-CM Diagnosis Code K75. Nonalcoholic fatty liver disease (NAFLD) Type 1 Excludes. Billable Thru Sept 30/2015. Background. K74 Fibrosis and cirrhosis of liver. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024. 0 - other international versions of ICD-10 K74. 6 : K00-K95. 81 - Nonalcoholic steatohepatitis (NASH) The above description is abbreviated. It is associated with visceral adiposity and the metabolic syndrome and is nearly as common as type 2 diabetes. Nonalcoholic steatohepatitis (NASH) is a more severe form of the spectrum of disease known as nonalcoholic fatty liver disease (NAFLD). Metabolism. The 2024 edition of ICD-10-CM K70. Steatohepatitis is a type of fatty liver disease, characterized by inflammation of the liver with concurrent fat accumulation in liver. | ICD-10 from 2011 - 2016 K75. During a biopsy, your doctor will insert a needle between your ribs into your liver to collect a small sample of liver tissue for laboratory testing. Fibrosis scores included APRI, NFS, Fib-4, and. Non-alcoholic steatohepatitis (NASH) is pathologically characterized by hepatic steatosis, hepatocyte ballooning, lobular and hepatic inflammation, and interstitial fibrosis 1,2. Nonalcoholic fatty liver disease (NAFLD) is a wide-spectrum disease entity from simple hepatic steatosis to nonalcoholic steatohepatitis. (14) A study from Israel reported an incidence rate of 28 per 1,000 person-years. 441 Disorders of liver except malignancy, cirrhosis or. codes reported an incidence rate for NAFLD of 29 per 100,000 person. This is the American ICD-10-CM version of K76 - other international versions of ICD-10 K76 may differ. 500 results found. Not Valid for Submission. While also a condition of fat in the liver, those with nonalcoholic steatohepatitis have liver inflammation and, usually, liver cell damage as. The 2024 edition of ICD-10-CM K71. The algorithm with the highest PPV of 100% on internal validation and 92% on external validation consisted of ≥ 3 counts of cirrhosis, no mention of alcohol (571. g. Learn how NASH can lead to some serious complications. Nonalcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in your liver. 81. 1 is a non-billable code. Results: The NAFLD classification algorithm included number of natural language mentions of NAFLD in the EMR, lifetime number of ICD-9 codes for NAFLD, and triglyceride level. , Ste. Nonalcoholic steatohepatitis (NASH) is the progressive form of nonalcoholic fatty liver disease (NAFLD), defined as the presence of ≥ 5% hepatic steatosis with inflammation and ballooning of hepatocytes, regardless of hepatic fibrosis []. NASH/NAFLD is the most common chronic liver disease. This is the American ICD-10-CM version of K70. NASH is a serious condition in which fat replaces healthy liver tissue in people who consume little or no alcohol. Biomarker Qualification Submission DDTBMQ000112: Imaging Biomarkers for Diagnosis of Nonalcoholic Steatohepatitis (FDA, 2021). 334 obeticholic acid improves experimental non‐invasive markers of non‐alcoholic steatohepatitis and advanced fibrosis; results of a secondary analysis from the month‐18 interim analysis of the REGENERATE study. Recent epidemiologic studies have shown that nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease in the US, with an estimated prevalence of 34% in the general population (based on screening using liver proton magnetic resonance spectroscopy). Both are characterized by hepatic steatosis, or abnormal retention of lipids in the liver, in the absence of excessive alcohol use, but NASH is associated with hepatocyte ballooning. 0 became effective on October 1, 2018. 8 ‘Other specified inflammatory liver diseases (non-alcoholic steatohepatitis)’ or K76. 8 should only be used for claims with a date of service on or before September 30, 2015. Nonalcoholic steatohepatitis (NASH) is a condition that causes inflammation and accumulation of fat and scar tissue in the liver. The 2024 edition of ICD-10-CM K72. 81 is grouped within Diagnostic Related Group(s) (MS-DRG v 41. It is a liver disease from the family of NAFLD (non-alcoholic fatty liver. If you have NASH and severe scarring of your liver, you may have some of the following signs and symptoms of cirrhosis: Intense itching. Save Saved. Synonyms: acute fatty liver of pregnancy, familial. No significant differences were observed regarding metabolic syndrome, type 2 diabetes mellitus, hypertension, dyslipidemia, rs662 polymorphism allele frequencies,. Nonalcoholic fatty liver disease (NAFLD) is becoming increasingly common, currently affecting approximately 37% of US adults. 81 [convert to ICD-9-CM] Nonalcoholic steatohepatitis (NASH) Nonalcoholic steatohepatitis; Steatohepatitis; Steatohepatitis (fatty inflammation of liver); code, if applicable, hepatic fibrosis (K74. 0-1. Short description: CHRONIC LIVER DIS NEC. Other chronic nonalcoholic liver disease (approximate match)Nonalcoholic fatty liver disease (NAFLD) encompasses hepatic steatosis, nonalcoholic steatohepatitis, and nonalcoholic steatohepatitis–related cirrhosis. Nonalcoholic steatohepatitis (NASH) K76. , 2005; Diehl and Day, 2017 ). K74. The aim of our study was to evaluate the efficacy of the 13C-Octanoate breath test (OBT) as a non-invasive surrogate marker to differentiate patients with NASH from patients with simple steatosis (NAFL). 1 contain annotation back-references that may be applicable to K70. The prevalence of NAFLD is estimated to be as high as 30%. 8: Chronic liver dis NEC: 573. 6%). 9 is applicable to adult patients aged 15 - 124 years inclusive. Treatment. Nonalcoholic Steatohepatitis or simply NASH is a liver condition in which fat buildup in the liver causes inflammation and liver damage [6, 13]. Patient Education. When treating NASH, doctors may recommend: aiming for a weight loss of at least 5–10% through exercise and. This is the American ICD-10-CM version of K70. 11 may differ. This is the American ICD-10-CM version of K74. Scan this QR code to be taken directly to the website. Although noninvasive diagnosis of NAFLD/NASH has progressed, pathological evaluation of liver biopsy specimens remains the gold standard. Both NAFLD and NASH are characterized by identification of > 5% hepatic steatosis in the absence of excessive alcohol consumption and other etiologies []. ICD-10-CM Coding Rules. The association of nonalcoholic steatohepatitis and hepatocellular carcinoma Eur J Gastroenterol Hepatol. Health Care Costs are Double for Nonalcoholic Fatty Liver Disease (NAFLD)/Nonalcoholic Steatohepatitis (NASH) Patients with Compensated Cirrhosis (CC) who Progress to End-Stage Liver Disease (ESLD). This commonly. Patients with nonalcoholic steatohepatitis (NASH), a subset of NAFLD, are at risk for progressive liver disease and in need of effective treatment options. Objective: The prevalence of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) cirrhosis is often underestimated in healthcare and administrative databases that define disease burden using International Classification of Diseases (ICD) codes. 4 NASH was detected in 12. To view the entire topic,. ICD-10-CM Codes; ICD-10-PCS Codes; Legacy ICD-9-CM Codes; Indexes . Alcoholic fatty liver. Applicable To. ICD-10-CM Index; ICD-10-CM External Causes Index; Table of Drugs; Table of Neoplasms; Conversion; DRG; Rules . 81 NASH code and liver biopsy); ICD-10 NASH (patients with an ICD-10 K75. Pasien yang kelebihan berat badan perlu menurunkan berat badan. (18–90 year) who had a diagnosis of OSA using the International Classification of Diseases ICD-9 codes. Natural history of NAFLD. Evidence of NASH included either a NASH ICD -10 diagnosis code or a NASH NLP affirmation. This topic will review the treatment and prognosis of NAFLD. nonalcoholic steatohepatitis (NASH) Advertise with Us | License ICD10 Data. S1238 Strategy of Combined ICD Codes and MELD Score Yields High Prevalence of Individuals With Non-Alcoholic Steatohepatitis (NASH) Cirrhosis That Are Eligible for Clinical Trials. Nonalcoholic fatty liver; Non-alcoholic fatty liver; Nonalcoholic steatohepatitis; Portal fibrosis without cirrhosis; Steatohepatitis; Steatohepatitis (fatty inflammation of liver) Steatohepatitis, nonalcoholic; Steatosis of liver; Yellow atrophy of liver, chronicNonalcoholic steatohepatitis; Steatohepatitis; Steatohepatitis (fatty inflammation of liver) Clinical Information. Applicable To. Although having fat in the liver is not normal, by itself it probably does not damage the liver. This list includes both the main, and any alternate names for each disease. Most patients with moderate disease are undernourished and present with fatigue, fever, jaundice, right upper quadrant pain, tender hepatomegaly, and sometimes a hepatic bruit. 81 may differ. The main treatment option for steatohepatitis is lifestyle modification. The new codes are as follows:K74. This is the American ICD-10-CM version of K75 - other international versions of ICD-10 K75 may differ. 81 NASH. It is unclear which specific patients progress from NAFL to NASH and, ultimately, to cirrhosis. ICD-10-CM Coding Rules. This was the first year ICD-10-CM was implemented into the HIPAA code set. 2014. This ICD-10 code translates to more than one ICD-9 code: 571. (2022) How To Code Chronic Constipation ICD 10 – List With Codes & Guidelines. National Digestive Diseases Information Clearinghouse . Code Classification: Diseases of the digestive system (K00–K93) Diseases of liver (K70-K77). NAFLD is the most common liver disease in the U. Evidence of NAFLD included either a NAFLD ICD -10 diagnosis code or a NAFLD NLP affirmation. Some patients with NAFLD progress to nonalcoholic. In fatty liver, fat accumulates in the liver cells. Inclusion ICD-9 code: In the ICD-9 branch of chronic liver disease (571) we will include 571. 2021 - New Code 2022 2023 2024 Billable/Specific Code. 0, S0-S3), and. NAFLD and NASH can be silent diseases with no symptoms at all or very mild symptoms such as tiredness and fatigue in early stages of the disease. Toxic liver disease. Introduction. This entity has not been described in pregnant women and could have obstetrical repercussions. In most clinical trials focusing on precirrhotic nonalcoholic steatohepatitis (NASH), a liver biopsy is required for confirmation of diagnosis, staging fibrosis, and grading steatohepatitis activity. Alcoholic cirrhosis with ascites; Ascites due to alcoholic cirrhosis. Patients diagnosed with other liver diseases with any ICD‐9 codes for viral, alcoholic, or cholestatic liver disease were excluded from the clinical NAFLD group. 0. 9 million patients in 2030 (~1/3 of the. 0. Healthcare Provider Information about Non-Alcoholic Steatohepatitis (NASH) NASH is a chronic liver disease characterized by liver cell injury (hepatocellular ballooning) and inflammation as a result of fatty accumulation (steatosis) seen in at least 5% of hepatocytes. 89 ICD-10-CM Code for Nonalcoholic steatohepatitis (NASH) K75. 6. 3%, respectively. Codes . Patients are diagnosed with NAFLD when secondary causes are not apparent (e. Data collection period: 2012 ICD-9 code was used to identify NASH patients in the OSA and control group: Frequency: NASH (overall): 0. Nonalcoholic steatohepatitis (NASH) is the critical stage in the development of nonalcoholic fatty liver disease (NAFLD) from simple and reversible steatosis to irreversible cirrhosis and even hepatocellular carcinoma (HCC). 2 Information Way . Nonalcoholic steatohepatitis (NASH) K75. ICD-10-CM; Newborn Codes; Pediatric Codes;. 1 result found: ICD-10-CM Diagnosis Code K75. ICD-10-CM Diagnosis Code K75. K75. Background Identifying past temporal trends in non-alcoholic steatohepatitis (NASH)-associated liver cancer (NALC) can increase public awareness of the disease and facilitate future policy development. , 1980; Kleiner et al. All tests were performed within a maximum of 72 h of each other, with the notable exception of the hepatic biopsy, which was performed within the previous 6-months. 8. Download the app!. The diagnosis and management of nonalcoholic fatty liver. 0 [convert to ICD-9-CM] INTRODUCTION. 2. An apoptosis panel for nonalcoholic steatohepatitis diagnosis. It also removes fat from the blood that has been released by other tissues in the body, for example, by fat cells. Nonalcoholic fatty liver disease (or NAFLD for short) is a buildup of fat in the liver that is not caused by drinking alcohol. Helpline 1-800-465-4837. 0. We identified the diagnosis of HCC in both study and control groups. 81); Nonalcoholic fatty liver disease (NAFLD) ICD-10-CM Diagnosis Code L72. 6 ‘Other and unspecified cirrhosis of liver’. nonalcoholic steatohepatitis (NASH) alcoholic K70. 0 for Fatty (change of) liver, not elsewhere classified is a medical classification as listed by WHO under the range - Diseases of the digestive system . -); Budd-Chiari syndrome (I82. 0) codes in the absence of any diagnosis codes for other common causes of chronic liver disease . It’s a rare and more serious form of nonalcoholic fatty liver. Nonalcohol-associated fatty liver disease (NAFLD) is a spectrum of disease characterized by hepatic steatosis in the absence of excessive alcohol consumption. ICD-9-CM 571. Find AGA's NASH Clinical Care Pathway App for iOS and Android mobile devices at nash. 00 Hepatic fibrosis, unspecified K74. K76. ICD-9-CM 571. 1 may differ. Hepatology 77 , 1335–1347 (2023). Our aims were to create and validate a noninvasive prediction model for NASH. 1–0. 10 - other international versions of ICD-10 K72. The 2019 Standards of Medical Care in Diabetes suggested that patients with nonalcoholic fatty liver disease (NAFLD) should be evaluated for liver fibrosis. 9 Inflammatory liver disease, unspecified;Chronic hepatitis c with stage 3 fibrosis; Chronic hepatitis c, stage 3 fibrosis; Hepatic fibrosis stage 3; underlying liver disease, such as:; nonalcoholic steatohepatitis (NASH) (K75. 85 versus 0. 75 (P < 0. 0 may differ. ICD-11 MMS code DB92. When using code K70. 1. Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis. 8. 81; Fatty liver, not elsewhere classified – K76. Subcohorts for analysis were created based on (1) NASH status: biopsy-confirmed NASH (patients with an ICD-10 K75. In the United States, about 100 million people have NAFLD. Zoli M, Melchionda N: Metformin in non-alcoholic steatohepatitis. K75. ICD-11 MMS code DB92 Non-alcoholic fatty liver disease with excludes, code elsewhere,. 8–571. NASH is defined as ≥5% hepatic steatosis along with hepatocellular injury. Nonalcoholic fatty liver disease is a manifestation of an abnormality of metabolism within the liver. Diagnosis Code for Reimbursement Claim: ICD-9-CM 571. Alcoholic cirrhosis; Alcoholic cirrhosis of liver. Order Code Order Code Name Order Loinc Result Code Result Code Name UofM Result LOINC; 504960: NASHnext (NIS4) 93692-2: 504964: NIS4 Test: 93692-2: Test Menu Right Side Menu. exclusions. Alcoholic cirrhosis with ascites; Ascites due to alcoholic cirrhosis. 9% of. This is the American ICD-10-CM version of K71. NAFLD encompasses a spectrum of severity ranging from typically non-progressive simple steatosis or nonalcoholic fatty liver (NAFL) to. Type 2 Excludes. steatosis with lobular inflammation and hepatocellular ballooning) [Citation 18] were also accepted, but not required, for the ICD-10 code to be considered valid. 5, K74. Patients are diagnosed with NAFLD when secondary causes are not apparent (e. Hepatitis B codes detected false-positive cases in patients with previous exposure (PPV 55. 2 The disease course can lead to advanced fibrosis. Nonalcoholic steatohepatitis (NASH) is the more severe form of NAFLD. Liver biopsy is an invasive procedure that carries a 0. 6 contain annotation back-references that may be applicable to K74. It is unclear which specific patients progress from NAFL to NASH and, ultimately, to cirrhosis. 41 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. 02: Hepatic fibrosis:. To prevent possible data-leakage, we only considered patient medical codes at least a month before the diagnosis of their respective ailment and manually deleted all medical codes corresponding to the diagnosis of NAFLD, NASH or liver biopsy test. Alcoholic cirrhosis; Alcoholic cirrhosis of liver. It may lead to cirrhosis and liver failure. The 2024 edition of ICD-10-CM K74. A blood-based biomarker panel (NIS4) for non-invasive diagnosis of non-alcoholic steatohepatitis and liver fibrosis: a prospective derivation and global validation study. The prevalence of NAFLD in the United States is reported to be between 10% and 30% , and the pooled overall global prevalence of NAFLD diagnosed by imaging was estimated to be greater than 25% . , 2016; Liu et al. K70. The tissue sample is looked at in a lab for signs of inflammation and scarring. 60 became effective on October 1, 2023. Save Saved. 8 should only be used for claims with a date of service on or before September 30, 2015. People typically develop one type of NAFLD or the other, although sometimes people with one form are later diagnosed with the other form of NAFLD. 30 [convert to ICD-9-CM] Alcoholic cirrhosis of liver without ascites. K70. Although a similar. (fatty inflammation of liver), steatohepatitis nonalcoholic, steatosis of liver, and yellow atrophy of liver chronic. As NASH progresses and liver damage gets worse, you may start to have symptoms such as: Fatigue (feeling tired all the time). 2010. 8 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 571. ICD-10-CM Coding Rules. 2024 ICD-10-CM Range K00-K95. The need for an effective treatment is both clear and urgent, yet in the absence of proven therapies, treatment is directed toward weight loss and comorbidity management. e. 2% of non-drinkers and 0. 81 Nonalcoholic steatohepatitis (NASH) K75. Billable Thru Sept 30/2015. 81 [convert to ICD-9-CM] Nonalcoholic steatohepatitis (NASH) Nonalcoholic steatohepatitis; Steatohepatitis; Steatohepatitis (fatty inflammation of liver); code, if applicable, hepatic fibrosis (K74. 10. A small group of people with NAFLD may have a more serious condition named non-alcoholic steatohepatitis (NASH). Short Description: Alcoholic fatty liver. Alcoholic hepatitis ranges from mild and reversible to life threatening. 9 (Unspecified chronic liver disease without mention of alcohol). Long Description: Alcoholic fatty liver. INTRODUCTION. The code is valid during the current fiscal year for the. Search Page 1/1: K7581. 65%: Singal et al. However, there is general consensus that, for those patients who do progress to cirrhosis (fibrosis stage 4), there is. ICD 10 CM K75. Background Non-alcoholic fatty liver disease (NAFLD) is the most common cause of liver disease worldwide. excessive alcohol consumption, medications, Wilson disease, or disorders of lipid metabolism) []. ECGs or ICD-9 code: Community-based 9333 individuals without baseline AF; aged 53–75 y: Prospective cohort: 12 y: Incident AF:. Cause of death was coded using the International Classification of Diseases (ICD) codes in use at the time of death (ICD‐8 for 1969‐1978, ICD‐9 for 1979‐1998, and ICD‐10 for 1999‐2016). The non-alcoholic steatohepatitis (NASH) market size is projected to reach $24. 1001/jama. Available for iPhone, iPad, Android, and Web. doi: 10. Clinical background. NASH: NASH stands for Non-Alcoholic Steatohepatitis. Unlike NAFLD, NASH is characterized by significant. 0000000000001681. Background Dyslipidemia and non-alcoholic fatty liver disease are well-known diseases and are part of a very broad spectrum evolving toward non-alcoholic steatohepatitis (NASH). The overall global prevalence of NAFLD is estimated to be 30%, and the associated clinical and economic burden will continue to. K00-K95. doi: 10. Nonalcoholic Steatohepatitis (NASH): Complications. Hepatitis, unspecified. The definitive diagnosis of non-alcoholic steatohepatitis was established using hepatic biopsy. 0)Nonalcoholic fatty liver disease (NAFLD) is the most common cause of abnormal serum aminotransferase levels in both developed and developing countries. The main characteristic of NAFLD is considered that the excessive fat is accumulated and. alcoholic liver disease ( K70. Chronic hepatic failure without coma. Applicable To. Non-Billable On/After Oct 1/2015. Steatosis and lobular inflammation are graded 0–3 based on severity, whereas ballooning is graded 0–2. org. Billable Thru Sept 30/2015. The diagnosis of alcoholic hepatitis is a clinical one with supporting laboratory findings of AH. 9 may differ. 9,10 Nonalcoholic steatohepatitis is also fuelingNon-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease that affects approximately one-quarter of the global adult population, posing a significant threat to human health with wide-ranging social and economic implications. Bariatric surgery is associated with reduction in non-alcoholic steatohepatitis and hepatocellular carcinoma: a propensity matched analysis. ContentsK75. 81) Hierarchy Tree View ICD-10; YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY. Qingfu Zhu, # 1 Hengrui Li, # 1 Zheng Ao, 6 Hao Xu, 1 Jiaxin luo, 1 Connor Kaurich, 6 Rui Yang, 1 Pei-Wu Zhu, 7 Sui-Dan Chen, 8 Xiao-Dong Wang, 5 Liang-Jie Tang, 3 Gang Li, 3 Ou-Yang Huang, 3 Ming-Hua Zheng, 3, 4, 5 Hui-Ping Li, 2. NAFLD is most often managed in. 30 [convert to ICD-9-CM] Alcoholic cirrhosis of liver without ascites. A silent disease with no symptoms or mild symptoms such as tiredness and fatigue in early stages. If you have NASH, you have inflammation and liver damage, along with fat in your liver. Non-alcoholic steatohepatitis (NASH) is becoming a global disease with significant associated comorbidities. The extrinsic death receptor-mediated pathway of apoptosis is involved in nonalcoholic steatohepatitis (NASH) development. Includes Excludes I Excludes II Notes From Section K70-K77:. Alcoholic cirrhosis; Alcoholic cirrhosis of liver. ICD-9-CM 571. Liver Diseases. This code was replaced on September 30, 2015 by its ICD-10 equivalent. Learn what factors determine a diagnosis for NASH. Nonalcoholic steatohepatitis (NASH), the severe form of NAFLD, can progress to liver cirrhosis and hepatocellular carcinoma (HCC).